N- Methyl- d -aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain
Open Access
- 2 March 1999
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (5) , 2508-2513
- https://doi.org/10.1073/pnas.96.5.2508
Abstract
Morbidity and mortality from head trauma is highest among children. No animal model mimicking traumatic brain injury in children has yet been established, and the mechanisms of neuronal degeneration after traumatic injury to the developing brain are not understood. In infant rats subjected to percussion head trauma, two types of brain damage could be characterized. The first type or primary damage evolved within 4 hr and occurred by an excitotoxic mechanism. The second type or secondary damage evolved within 6–24 hr and occurred by an apoptotic mechanism. Primary damage remained localized to the parietal cortex at the site of impact. Secondary damage affected distant sites such as the cingulate/retrosplenial cortex, subiculum, frontal cortex, thalamus and striatum. Secondary apoptotic damage was more severe than primary excitotoxic damage. Morphometric analysis demonstrated that the N-methyl-d-aspartate receptor antagonists 3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonate and dizocilpine protected against primary excitotoxic damage but increased severity of secondary apoptotic damage. 2-Sulfo-α-phenyl-N-tert-butyl-nitrone, a free radical scavenger, did not affect primary excitotoxic damage but mitigated apoptotic damage. These observations demonstrate that apoptosis and not excitotoxicity determine neuropathologic outcome after traumatic injury to the developing brain. Whereas free radical scavengers may prove useful in therapy of head trauma in children, N-methyl-d-aspartate antagonists should be avoided because of their propensity to increase severity of apoptotic damage.Keywords
This publication has 22 references indexed in Scilit:
- Marked age‐dependent neuroprotection by brain‐derived neurotrophic factor against neonatal hypoxic—ischemic brain injuryAnnals of Neurology, 1997
- Brain injury in the Commonwealth of Virginia: an analysis of Central Registry data, 1988-1993Brain Injury, 1996
- Excitotoxicity and neurodegenerative diseasesCurrent Opinion in Neurology, 1995
- Strategies for Neuroprotection with Glutamate AntagonistsAnnals of the New York Academy of Sciences, 1995
- Delayed and Progressive Brain Injury in Children and Adolescents with Head TraumaPediatric Neurosurgery, 1995
- Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonistsNature, 1991
- The Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain InjuryScience, 1989
- The influence of immaturity on hypoxic‐ischemic brain damage in the ratAnnals of Neurology, 1981
- An improved cupric-silver method for impregnation of axonal and terminal degenerationBrain Research, 1971
- Brain Damage in Infant Mice following Oral Intake of Glutamate, Aspartate or CysteineNature, 1970